These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Spinocerebellar degeneration with parkinsonian features: a clinical and pathological report. Weir RL; Fan KJ Ann Neurol; 1981 Jan; 9(1):87-9. PubMed ID: 7212673 [TBL] [Abstract][Full Text] [Related]
4. [SUPPLEMENTARY REMARKS ON THE KNOWLEDGE OF SPINOPONTOCEREBELLAR ATROPHY AND ON THE PROBLEM OF CELLULAR METABOLISM]. KRAUS-RUPPERT R Arch Psychiatr Nervenkr; 1964 Jul; 205():409-32. PubMed ID: 14251290 [No Abstract] [Full Text] [Related]
5. A SEX-LINKED HEREDO-DEGENERATIVE NEUROLOGICAL DISORDER ASSOCIATED WITH LEBER'S OPTIC ATROPHY. GENETICAL ASPECTS. WENT LN Acta Genet Stat Med; 1964; 14():220-39. PubMed ID: 14220464 [No Abstract] [Full Text] [Related]
6. DEMYELINATING CENTRAL NERVOUS SYSTEM DISEASE, MACULAR ATROPHY AND ACANTHOCYTOSIS (BASSEN-KORNZWEIG SYNDROME). SOBREVILLA LA; GOODMAN ML; KANE CA Am J Med; 1964 Nov; 37():821-8. PubMed ID: 14237436 [No Abstract] [Full Text] [Related]
8. [Cerebellar atrophy associated with lesions of the pallidum and luys' body and presence of lewy bodies. Relationships with degenerative disorders of the pallidum, substantia nigra and luys' body (author's transl)]. Morin P; Lechevalier B; Bianco C Rev Neurol (Paris); 1980; 136(5):381-90. PubMed ID: 7466122 [TBL] [Abstract][Full Text] [Related]
15. No parkinsonism in SCA2 and SCA3 despite severe neurodegeneration of the dopaminergic substantia nigra. Schöls L; Reimold M; Seidel K; Globas C; Brockmann K; Hauser TK; Auburger G; Bürk K; den Dunnen W; Reischl G; Korf HW; Brunt ER; Rüb U Brain; 2015 Nov; 138(Pt 11):3316-26. PubMed ID: 26362908 [TBL] [Abstract][Full Text] [Related]
16. [An autopsy case of multiple system atrophy with many Lewy bodies--striatonigral degeneration, olivo-ponto-cerebellar atrophy and autonomic nerve nucleus involvement in the spinal cord]. Morioka E; Kuroda S; Kuyama K; Otsuki S; Hosokawa K; Namba R No To Shinkei; 1987 Apr; 39(4):361-6. PubMed ID: 3036191 [TBL] [Abstract][Full Text] [Related]
17. SUBSTANTIA NIGRA AND PARKINSONISM. METTLER FA Arch Neurol; 1964 Nov; 11():529-42. PubMed ID: 14200661 [No Abstract] [Full Text] [Related]
18. [THE MECHANISMS OF DAMAGE TO THE SUBSTANTIA NIGRA IN BRAIN TRAUMAS AND THE PROBLEM OF POSTTRAUMATIC PARKINSONISM]. LINDENBERG R Dtsch Z Nervenheilkd; 1964 Feb; 185():637-63. PubMed ID: 14158296 [No Abstract] [Full Text] [Related]
19. [CLINICO-PATHOLOGICAL STUDIES ON THE MIDBRAIN, WITH SPECIAL REFERENCE TO THE SUBSTANTIA NIGRA AND RIGIDITY]. OTOMO E; KAMEYAMA M; MANNEN T Yokufuen Chosa Kenkyu Kiyo; 1964 Jul; 39():57-63. PubMed ID: 14201055 [No Abstract] [Full Text] [Related]
20. Treatment of demyelinating and degenerative diseases by electro stimulation of the spinal cord. Dooley DM; Sharkey J; Keller W; Kasprak M Med Prog Technol; 1978 Nov; 6(1):1-14. PubMed ID: 310508 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]